Tobramycin 0.3%/Dexamethasone 0.05% Ophthalmic Suspension
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Tobramycin 0.3%/Dexamethasone 0.05% Ophthalmic Suspension, covering 2010-01-14 to 2010-01-14. Get the full timeline:
Most recent: Clinical Trial Update: TOBRADEX Ophthalmic Suspension Versus Tobramycin 0.3%/Dexamethasone 0.05% Ophthalmic Suspension [Phase 3]